Robert Hugin, Celgene chairman & CEO, explains why Celgene's 2012 earnings will top expectations on Wall Street. He also discusses the company's growing interest in emerging markets.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT